2 High-Growth Stocks to Buy Right Now
Despite all the political rhetoric over drug prices in the United States, biotech stocks, on balance, have still had a respectable year. The closely watched iShares Nasdaq Biotechnology ETF is presently up by over 6% for the year and brighter days should be close at hand with the ongoing innovation bonanza showing no signs of cooling off.
Which biotech stocks should investors have on their radars right now? The rare-disease specialists BioMarin Pharmaceutical (NASDAQ: BMRN) and Vertex Pharmaceuticals (NASDAQ: VRTX) are both poised to produce market-beating returns in the coming decade. Here's what you need to know about these top biotech growth stocks.
Image source: Getty Images.
Source Fool.com
